Area of research
Oncology · Hepatology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, and Cancer Genomics and Diagnostics.
Potential association between <scp> <i>PSCA</i> rs2976395 </scp> functional variant and pancreatic cancer risk
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer
Genetic and non-genetic risk factors for early-onset pancreatic cancer
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
Association between a polymorphic variant in the <i>CDKN2B‐AS1/ANRIL</i> gene and pancreatic cancer risk
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
Association of genetic variants affecting microRNAs and pancreatic cancer risk
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Germline <i>BRCA2</i> K3326X and <i>CHEK2</i> I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study
Genetic variability of the ABCC2 gene and overall survival in pancreatic cancer
SLC22A3 polymorphisms may influence overall patient survival- PANDORA study
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation
Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study
Rare BRCA2 K3326X increases susceptibility to sporadic pancreatic ductal adenocarcinoma: A PANDoRA study
Abstract 3411: Rare BRCA2 K3326X increases susceptibility to sporadic pancreatic ductal adenocarcinoma: a PANDoRA study
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients
Functional polymorphisms in the CDKN2A- CDKN2B gene regions affect pancreatic cancer risk
Functional polymorphisms in the CDKN2A generegion affect pancreatic cancer risk
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer
<scp><i>TERT</i></scp> gene harbors multiple variants associated with pancreatic cancer susceptibility
Novel pancreatic cancer susceptibility loci discovered through genome-wide association studies